Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rituximab for the treatment of type II mixed cryoglobulinemia.

× No keyword cloud information.

14 in total

Review 1. Biologic therapies: what and when?

Authors: Sarah L Johnston
Journal: J Clin Pathol Date: 2007-01 Impact factor: 3.411

2. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.

Authors: J-E Gottenberg; L Guillevin; O Lambotte; B Combe; Y Allanore; A Cantagrel; C Larroche; M Soubrier; L Bouillet; M Dougados; O Fain; D Farge; X Kyndt; O Lortholary; C Masson; B Moura; P Remy; T Thomas; D Wendling; J-M Anaya; J Sibilia; X Mariette
Journal: Ann Rheum Dis Date: 2004-11-18 Impact factor: 19.103

Review 3. Rheumatic manifestations of hepatitis C infection.

Authors: Dimitrios Vassilopoulos; Leonard H Calabrese
Journal: Curr Rheumatol Rep Date: 2003-06 Impact factor: 4.592

Review 4. Successful treatment of relapsing autoimmune pancreatitis in primary Sjögren's syndrome with rituximab: report of a case and review of the literature.

Authors: Juan C Rueda; Carolina Duarte-Rey; Nohemi Casas
Journal: Rheumatol Int Date: 2009-01-11 Impact factor: 2.631

Review 5. Hepatitis C virus-related lymphoproliferative disorders: an overview.

Authors: Anna-Linda Zignego; Carlo Giannini; Clodoveo Ferri
Journal: World J Gastroenterol Date: 2007-05-07 Impact factor: 5.742

Review 6. B-cell-directed therapies for autoimmune disease.

Authors: Thomas Dörner; Andreas Radbruch; Gerd R Burmester
Journal: Nat Rev Rheumatol Date: 2009-07-07 Impact factor: 20.543

Review 7. Management of rheumatic disease with comorbid HBV or HCV infection.

Authors: Dimitrios Vassilopoulos; Leonard H Calabrese
Journal: Nat Rev Rheumatol Date: 2012-05-08 Impact factor: 20.543

8. Abnormal B-cell activation associated with TALL-1 over-expression and SOCS-1 suppression during chronic hepatitis C virus infection.

Authors: Jonathan Moorman; Zhi P Dong; Lei Ni; Chunlan Zhang; Thomas Borthwick; Zhi Q Yao
Journal: Immunology Date: 2009-10 Impact factor: 7.397

9. Differential regulation of SOCS-1 signalling in B and T lymphocytes by hepatitis C virus core protein.

Authors: Zhi Qiang Yao; Deborah Prayther; Christopher Trabue; Zhi Ping Dong; Jonathan Moorman
Journal: Immunology Date: 2008-04-04 Impact factor: 7.397

Review 10. Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact.

Authors: Anna Linda Zignego; Carlo Giannini; Laura Gragnani; Alessia Piluso; Elisa Fognani
Journal: J Transl Med Date: 2012-08-03 Impact factor: 5.531